Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000332 · ClinicalTrials.gov registry record · Phase 2
High Dose Nimodipine Treatment Adjunct - 1
A Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 2
- Development phase
NCT00000332: Completed Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
NCT00000332 is a Phase 2 study that has completed, run by National Institute on Drug Abuse (NIDA). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000332, a Phase 2 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to determine if nimodipine is more effective than placebo in reducing stimulated craving for cocaine in cocaine dependent individuals denied access to cocaine in inpatient unit.
Interventions
- DRUG Nimodipine
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-05 |
| Est. Completion | 2000-04 |
| Phase | Phase 2 |
What the finished NCT00000332 record still lists
NCT00000332 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Nimodipine is the first listed.
NCT00000332 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000332 about?
NCT00000332 is a clinical study titled "High Dose Nimodipine Treatment Adjunct - 1". The purpose of this study is to determine if nimodipine is more effective than placebo in reducing stimulated craving for cocaine in cocaine dependent individuals denied access to cocaine in inpatient unit.
What is the current status of trial NCT00000332?
This trial is currently completed. It is a Phase 2 study. The study started on 1998-05. Estimated completion is 2000-04.
What interventions are being tested in trial NCT00000332?
The interventions under investigation include: Nimodipine (DRUG).
Who is sponsoring clinical trial NCT00000332?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia